Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01402661 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry

StatusEnrolling by Invitation
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    v15
  2. Trial status: Enrolling by Invitation to Recruitingv14 Show 4 more changesShow less
    • Eligibility criteria revised
    • Study description revised
    • Study site revised
    • Study title revised
  3. 2 versions Re-verified since Nov 9, 2022, no change to tracked fieldsv12-v13
  4. Enrollment target: 33312 to 91758
    • Study completion date: Dec 2100
    v11
  5. Study title expanded, about 3 wordsv10
Show 8 earlier versionsHide 8 earlier versions
  1. Study description shortened, about 302 wordsv9
  2. Eligibility criteria expanded, about 192 wordsv8
  3. Re-verified, no change to tracked fieldsv7
  4. Eligibility criteria expanded, about 76 wordsv6
  5. Re-verified, no change to tracked fieldsv5
  6. Primary completion date: Dec 2100
    • Eligibility criteria expanded, about 24 words
    • Study description shortened, about 1,628 words
    • Study title expanded, about 1 word
    v4
  7. Re-verified, no change to tracked fieldsv3
  8. Study sites: 5 to 1v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for RA in a cohort of patients cared for by rheumatologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Trial Details
NCT Number NCT01402661
Lead Sponsor CorEvitas
Collaborators: University of Massachusetts, Worcester, University of Alabama at Birmingham, Brigham and Women's Hospital
Conditions
(from sponsor)		 Rheumatoid Arthritis
Related terms Arthritis, Psoriatic, Arthritis, Rheumatoid
Enrollment 91,758 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov